Lenz Therapeutics Inc (LENZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,117 | -26,902 | -16,648 | -69,968 | -46,276 |
| Depreciation Amortization | 33 | -1,211 | -270 | -1,042 | -535 |
| Accounts payable and accrued liabilities | -5,599 | -3,955 | -1,269 | 856 | -232 |
| Other Working Capital | -16,418 | -15,210 | -9,013 | 9,410 | 6,430 |
| Other Operating Activity | 8,788 | 7,546 | 3,263 | 364 | 1,203 |
| Operating Cash Flow | $-50,313 | $-39,732 | $-23,937 | $-60,380 | $-39,410 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -319 | -133 | N/A | -30 | -30 |
| Purchase Of Investment | -195,297 | -111,257 | N/A | -52,091 | -46,264 |
| Sale Of Investment | 53,000 | 31,000 | 18,000 | 22,500 | 1,500 |
| Investing Cash Flow | $-142,616 | $-80,390 | $18,000 | $-29,621 | $-44,794 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 83,498 | 53,667 | 53,817 | 203 | 203 |
| Other Financing Activity | 115,451 | 115,464 | 117,451 | 80,497 | 82,408 |
| Financing Cash Flow | $198,949 | $169,131 | $171,268 | $80,700 | $82,611 |
| Beginning Cash Position | 35,140 | 35,140 | 35,140 | 44,441 | 44,441 |
| End Cash Position | 41,160 | 84,149 | 200,471 | 35,140 | 42,848 |
| Net Cash Flow | $6,020 | $49,009 | $165,331 | $-9,301 | $-1,593 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,313 | -39,732 | -23,937 | -60,380 | -39,410 |
| Capital Expenditure | -319 | -133 | N/A | -30 | -30 |
| Free Cash Flow | -50,632 | -39,865 | -23,937 | -60,410 | -39,440 |